Manifestations of late radiation urethritis in comparison with instrumental assessments of the spatial intra-cavity distribution of doses in the organ after high dose rate brachytherapy of prostate cancer with the use of Ir-192: preliminary results

«Radiation and Risk», 2019, vol. 28, No. 1, pp.110-123

DOI: 10.21870/0131-3878-2019-28-1-110-123

Authors

Korotkov V.A. – Head of Dep.
Kaprin A.D. – General Director NMRCR, Academician of RAS, MD, Prof.
Ivanov S.A. – Director, MD, Prof.
Stepanenko V.F. – Head of Lab., D. Sc., Biol., Prof. Contacts: 4 Korolyev str., Obninsk, Kaluga region, 249036, Russia. Tel.: +7 (484) 399-70-02; e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .
Biryukov V.A. – Sen. Res., C. Sc., Med.
Borisheva N.B. – Head of Dep., C. Sc., Phys.-Math.
Kolyzhenkov T.V. – Sen. Res., C. Sc., Biol.
Akhmedova U.A. – Researcher.
Bogacheva V.V. – Researcher.
Petukhov A.D. – Researcher.
Zharova E.P. – Scientific Secretary.

A. Tsyb MRRC, Obninsk.
¹ NMRCR Russian Ministry of Health, Moscow

Abstract

The technology of instrumental (in vivo) measurements of spatial intracavity distribution of absorbed dose in the urethra and rectum using autonomous luminescent microdosimeters was developed and applied in A. Tsyb MRRC as a part of the quality assurance program of high dose rate brachytherapy for prostate cancer using 192Ir source and in order to take adequate measures after radiotherapy regarding possible complications of irradiation. At the end of 2018 in vivo measurements of the spatial distribution of absorbed doses in the urethra and rectum were performed among 50 patients (30 of them in 2017). During first year after radiotherapy there were no complaints from patients that are specific for radiation complications. A year after brachytherapy, an active survey of 30 patients cured in 2017 was conducted regarding complaints related to the urethra and rectum. In relation to rectum no complaints were presented. Six of these 30 patients presented complaints regarding urethra. These complaints (at the time of the survey) can be interpreted as manifestations of late radiation urethritis. The results of in vivo measurements of the spatial distribution of absorbed doses show that the values of the measured doses are in good agreement with the results of the planned (calculated) doses in the urethra and rectum in those patients who have not presented complaints. Meanwhile, in six patients (among 30 patients who underwent brachytherapy, and who presented complaints about the urethra a year after radiotherapy), the significant excesses of the measured doses compared with the planned (calculated) dose were estimated. For these six patients, the maximum values of the measured absorbed doses in the urethra (prostatic part of urethra) are ranged from 18 to 25 Gy (from patient to patient) with a measurement’s accuracy of 5%. The measured maximum absorbed doses in rádix pénis, where the estimated (planned) doses are not available, are ranged from 3 to 6 Gy with a measurement’s accuracy of 5%.

Key words
In vivo dosimetry, luminescence dosimetry, intracavity dosimetry, spatial distribution of absorbed doses, TL microdosimeters LiF(Mg,Ti), flexible microdosimetric assemblies, calculated planned absorbed doses, brachytherapy, 192Ir, rectum, urethra, manifestation of late radiation ure-thritis.

References

1. WHO. Radiotherapy Risk Profile WHO/IER/PSP/2008.12. Geneva, WHO, 2008. 51 p. Available at: http://www.who.int/patientsafety/activities/technical/radiotherapy_risk_profile.pdf (Accessed 15 December 2018).

2. IAEA. Lessons learned from accidental exposures in radiotherapy. IAEA Safety Report Series 17. Vienna, IAEA, 2000. 96 p. Available at: http://www-pub.iaea.org/mtcd/publications/pdf/pub1084_web.pdf (Accessed 19 April 2017).

3. IAEA. IAEA Human Health Reports No. 8. Development of Procedures for In Vivo Dosimetry in Radiotherapy. Vienna, IAEA, 2013. 178 p. Available at: http://www-pub.iaea.org/mtcd/publications/pdf/ pub1084_web.pdf (Accessed 19 April 2018).

4. ICRP, 2005. Prevention of high-dose-rate brachytherapy accidents. ICRP Publication 97. Ann. ICRP, 2005, vol. 35, no. 2, pp. 1-51.

5. Kaprin A.D., Galkin V.N., Ivanov S.A. Rol' brahiterapii v lechenii lokalizovannyh form raka predstatel'noj zhelezy [The role of brachytherapy in the treatment of localized prostate cancer]. Biomedical Photonics, 2015, vol. 4, no. 4, pp. 21-26.

6. Ivanov S.A. Brakhiterapiya kak metod radikal'nogo lecheniya pri rake predstatel'noy zhelezy. Diss. dokt. med. nauk [Brachytherapy as a method of radical treatment of prostate cancer. Dr. med. sci. diss.]. Moscow, 2011. 265 p.

7. Ivanov S.A., Kaprin A.D., Milenin K.N., Al'bickij I.A., Ivanenko K.V. Rezul'taty primeneniya nizkodoznoy brakhiterapii v kachestve radikal'nogo lecheniya pri rake predstatel'noy zhelezy [Results of application of low-dose brachytherapy as a radical treatment of prostate cancer]. Diagnosticheskaya i interventsionnaya radiologiya – Diagnostical and Interventional Radiology, 2015, vol. 5, no. 1, pp. 73-76.

8. Kaprin A.D., Pan'shin G.A., Al'bickij I.A., Milenin K.N., Cybul'skij A.D. Brakhiterapiya lokalizovannogo raka predstatel'noy zhelezy (meditsinskaya tekhnologiya [Brachytherapy of localized prostate cancer: medi-cal technology]. Available at: http://www.rncrr.ru/nauka/new-technology/brakhiterapiya-lokalizovannogo-raka-predstatelnoy-zhelezy (Accessed 25 January 2018).

9. Brachytherapy. Eds.: Acad. RAS A.D. Kaprin, Corr. Member RAS Yu.S. Mardinskiy. Obninsk, A. Tsyb MRRC, 2017. 245 p. (In Russian).

10. Merrick G.S., Butler W.M., Wallner K.E., Galbreath R.W., Anderson R.L., Allen Z.A., Adamovich E. Risk factors for the development of prostate brachytherapy related urethral strictures. J. Urol., 2006, vol. 175, no. 4, pp. 1376-1381.

11. Moltzahn F., Dal Pra A., Furrer M., Thalmann G., Spahn M. Urethral strictures after radiation therapy for prostate cancer. Investig. Clin. Urol., 2016, vol. 57, no. 5, pp. 309-315.

12. Viswanathan A.N., Yorke E.D., Marks L.B., Eifel P.J., Shipley W.U. Radiation dose-volume effects of the urinary bladder. Int. J. Radiat. Oncol. Biol. Phys., 2010, vol. 76, no. 3 (Suppl.), pp. S116-S122.

13. Herschorn S., Elliott S., Coburn M., Wessells H., Zinman L. SIU/ICUD Consultation on Urethral Strictures: Posterior urethral stenosis after treatment of prostate cancer. Urology, 2014, vol. 83, no. 3 (Suppl.), pp. S59-S70.

14. Aström L., Pedersen D., Mercke C., Holmang S., Johansson K.A. Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer. Radiother. Oncol., 2005, vol. 74, no. 2, pp. 157-161.

15. Toye W., Das R., Kron T., Franich R., Johnston P., Duchesne G. An in vivo investigative protocol for HDR prostate brachytherapy using urethral and rectal thermoluminescence dosimetry. Radiother. Oncol., 2009, vol. 91, no. 2, pp. 243-248. DOI: 10.1016/j.radonc.2008.08.016.

16. Therriault-Proulx F., Briere T.M., Mourtada F., Aubin S., Beddar S., Beaulieu L. A phantom study of an in vivo dosimetry system using plastic scintillation detectors for real-time verification of 192Ir HDR brachytherapy. Med. Phys., 2011, vol. 38, no. 5, pp. 2542-2551. DOI: 10.1118/1.3572229.

17. Andersen C.E., Nielsen S.K., Greilich S., Helt-Hansen J., Lindegaard J.C., Tanderup K. Characterization of a fiber-coupled Al2O3:C luminescence dosimetry system for online in vivo dose verification during 192Ir brachytherapy. Med. Phys., 2009, vol. 36, no. 3, pp. 708-718. DOI: 10.1118/1.3063006.

18. Stepanenko V.F., Birjukov V.A., Karjakin O.B., Kaprin A.D., Galkin V.N., Ivanov S.A., Mardynskij Ju.S., Kolyzhenkov T.V., Petuhov A.D., Bogacheva V.V., Ahmedova U.A., Jas'kova E.K., Lepilina O.G., Sanin D.B., Skvortsov V.G., Ivannikov A.I., Hajlov A.M., Anohin Ju.N. Lokal'nye pogloshchennye dozy oblucheniya meditsinskogo personala pri brakhiterapii raka predstatel'noy zhelezy mikroistochnikami 125I rossiyskogo proizvodstva [Local absorbed doses of irradiation of medical personnel at brachytherapy of prostate cancer using 125I microsources of Russian production]. Radiatsiya i risk – Radiation and Risk, 2017, vol. 26, no. 1, pp. 44-59.

19. Bernhardsson C., Christiansson M., Raaf C., Mattssonosl S. OSL in household salt (NaCl) for enviro-mental, occupational and medical dosimetry. Medical Physics in the Baltic States 7 (2009). Medical Physics 2009: Proceedings of the International Conference. 9-10 October 2009, Kaunas, Lithuania. pp. 65-68.

20. Christiansson M. Household salt as an emergency radiation dosimeter for retrospective dose assessments using optically stimulated luminescence: Doctoral Thesis. Lund, Lund University, 2014. 136 p.

21. Stepanenko V.F., Biryukov V.A., Kaprin A.D., Galkin V.N., Ivanov S.A., Borysheva N.B., Kariakin O.B., Mardinskiy Yu.S., Gulidov I.A., Kolyzhenkov T.V., Obukhov A.A., Ivannikov A.I., Skvortsov V.G., Akhmedova U.A., Bogacheva V.V., Petukhov A.D., Yaskova E.K., Khailov A.M., Lepilina O.G., Sanin D.B., Korotkov V.A., Anokhin Yu.N. «In vivo» dozimetriya pri vysokomoshchnostnoy brakhiterapii raka predstatelnoy zhelezy s primeneniyem 192Ir: sravneniye raspredeleniya planiruyemykh i izmerennykh doz pri vnutripolostnom razmeshchenii avtonomnykh lyuminestsentnykh mikrodozimetrov. [In vivo dosimetry at high dose rate brachytherapy for prostate cancer using 192Ir: comparison of dose distribution between planned and measured doses with intracavitary placement of autonomous luminescence microdosimeters]. Radiatsiya i risk – Radiation and Risk, 2018, vol. 27, no. 1, pp. 77-85.

22. Stepanenko V.F., Biryukov V.A., Kaprin A.D., Galkin V.N., Ivanov S.A., Kariakin O.B., Mardinskiy Yu.S., Gulidov I.A., Kolyzhenkov T.V., Ivannikov A.I., Borysheva N.B., Skvortsov V.G., Akhmedova U.A., Bogacheva V.V., Petukhov A.D., Yaskova E.K., Khailov A.M., Lepilina O.G., Sanin D.B., Korotkov V.A., Obukhov A.A., Anokhin Yu.N. Vnutripolostnaya avtonomnaya «in vivo» dozimetriya pri vysoko-moshchnostnoy brakhiterapii raka predstatel'noy zhelezy c primeneniem 192Ir: razrabotka tekhnologii i per-vye rezul'taty [Intracavitary offline "in vivo" dosimetry for high dose-rate prostate brachytherapy with 192Ir: development of technology and first results of its application]. Radiatsiya i Risk – Radiation and Risk, 2017, vol. 26, no. 2, pp. 72-82.

23. Kaprin A.D., Galkin V.N., Zhavoronkov L.P., Ivanov V.K., Ivanov S.A., Romanko Yu.S. Sintez funda-mental'nykh i prikladnykh issledovaniy – osnova obespecheniya vysokogo urovnya nauchnykh rezul'tatov i vnedreniya ikh v meditsinskuyu praktiku [Synthesis of basic and applied research is the basis of obtaining high-quality findings and translating them into clinical practice]. Radiatsia i Risk – Radiation and Risk, 2017, vol. 2, no. 2, pp. 26-40.

Full-text article (in Russian)